 | • レポートコード：MRC2203A176 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：IT |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界のケモインフォマティクス市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（化学分析、創薬・検証、仮想スクリーニング、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のケモインフォマティクス市場規模：用途別（化学分析、創薬・検証、仮想スクリーニング、その他） ・世界のケモインフォマティクス市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Dassault Systemes、Agilent Technologies、BioSolveIT、…） ・市場機会・将来傾向 |
The chemoinformatics market is expected to register a CAGR of nearly 15.5% during the forecast period (2021 – 2026).
The propelling factors for the growth of the global chemoinformatics market include the innovations and advancements in the drug development process and increased demand for personalized medicine. The ever increasing growth of the drug development market is likely to boost the demand for chemoinformatics, owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.
There has also been growing awareness related to personalized medicine, which has been driving the demand for effective medication, coupled with the unsustainable burden of chronic diseases. This serves as a compelling factor for new drug development, which promotes a positive impact on the growth of the global chemoinformatics market. These techniques find a vast array of applications in the various stages of drug designing. Furthermore, with the growing R&D intensity, the segment is further reinforced, owing to technological innovation inputs.
Key Market Trends
Chemical Analysis Segment by Application is Expected to Grow Fastest Over the Forecast Period
The chemical analysis segment accounted for the majority of the revenue share. The major factors that are contributing to the segment’s growth include the increasing investments in R&D and the relatively low success rate of the potential leads as drug molecules.
The factors in conjunction with each other are expected to boost the usage of these platforms. Increasing demand for personalized medicine is a major cause for the market growth. Increasing prevalence of concerned other chronic diseases, which boosts demand for personalized diagnostics and therapeutics, is also one of the key factors responsible for the growth of the segment.
North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period
North America is likely to contribute to the largest share in the chemoinformatics market, owing to factors, such as enhanced healthcare of infrastructure, funds in initiatives of R&D, and technological enlargements in the United States and Canada. There has also been an increasing patient awareness about healthcare services and growing demand for personalized medicine that are likely to boost the market growth.
Competitive Landscape
The global chemoinformatics market has gained significant momentum in research institutions, pharmaceutical companies, biotechnology industry, research laboratories, and academic institutions. Therefore it is expected that over the course of time, there may be an influx of well-established players in the chemoinformatics market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Innovations and Advancements in the Drug Development Process
4.2.2 Increased Demand of Personalized Medicine
4.3 Market Restraints
4.3.1 Lack of Integration of a Wide Variety of Data Generated Through Various Platforms
4.3.2 Lack of Skilled Labors
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Chemical Analysis
5.1.1.1 Chemical Databases
5.1.1.2 Chemo metrics
5.1.1.3 Molecular Modelling
5.1.1.4 Other Chemical Analyses
5.1.2 Drug Discovery and Validation
5.1.3 Virtual Screening
5.1.4 Other Applications
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Dassault Systemes
6.1.2 Agilent Technologies
6.1.3 BioSolveIT
6.1.4 Aureus Pharma
6.1.5 ChemAxon Inc
6.1.6 Scilligence
6.1.7 Chemical Computing Group Inc.
6.1.8 Jubilant Biosys Inc.
6.1.9 Molecular Discovery Ltd
6.1.10 OpenEye Scientific Software
7 MARKET OPPORTUNITIES AND FUTURE TRENDS